The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental and Translational Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas.
The Programme draws on the world-class research and teaching in experimental therapeutics at Oxford University and offers a unique opportunity to gain an understanding of the principles that underpin clinical research and to translate this into good clinical and research practice.
Visit the website https://www.conted.ox.ac.uk/about/msc-in-experimental-therapeutics
If your application is completed by this January deadline and you fulfil the eligibility criteria, you will be automatically considered for a graduate scholarship. For details see: http://www.ox.ac.uk/admissions/graduate/fees-and-funding/graduate-scholarships.
The MSc in Experimental and Translational Therapeutics is a part-time course consisting of six modules and a research project and dissertation. The programme is normally completed in two to three years. Students are full members of the University of Oxford and are matriculated as members of an Oxford college.
The modules in this programme can also be taken as individual short courses. It is possible to transfer credit from up to three previously completed modules into the MSc programme, if the time elapsed between commencement of the accredited module(s) and registration for the MSc is not more than two years.
- The Structure of Clinical Trials and Experimental Therapeutics
- Drug Development, Pharmacokinetics and Imaging
- Pharmacodynamics, Biomarkers and Personalised Therapy
- Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance
- How to do Research on Therapeutic Interventions: Protocol Preparation
- Biological Therapeutics
The aim of the MSc programme is to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical and research practice.
By the end of the MSc programme, students should understand the following core principles:
- Development, marketing and regulations of drugs
- Pharmaceutical factors that affect drug therapy
- Pharmacokinetics, pharmacogenetics and pharmacodynamics
- Adverse drug reactions, drug interactions, and pharmacovigilance
- Designing phase I, II and III clinical trials for a range of novel therapeutic interventions (and imaging agents).
- Application of statistics to medicine
- Laboratory assays used to support trial end-points
- Use of non-invasive imaging in drug development
- Application of analytical techniques
By the end of the programme, students should be equipped to:
- demonstrate a knowledge of the principles, methods and techniques for solving clinical research problems and translate this into good clinical and research practice
- apply skills gained in techniques and practical experience from across the medical and biological sciences
- develop skills in managing research-based work in experimental therapeutics
- carry out an extended research project involving a literature review, problem specification and analysis in experimental therapeutics and write a short dissertation
Guidance from the UK Royal College of Physician's Faculty of Pharmaceutical Medicine
The Faculty have confirmed that if enrolled for Pharmaceutical Medicine Specialty Training (PMST), trainees may be able to use knowledge provided by Experimental Therapeutics modules to cover aspects of a module of the PMST curriculum. Trainees are advised to discuss this with their Educational Supervisor.
Experimental Therapeutics modules may also be used to provide those pursuing the Faculty's Diploma in Pharmaceutical Medicine (DPM) with the necessary knowledge required to cover the Diploma syllabus. Applicants for the DPM exam are advised to read the DPM syllabus and rules and regulations.
Members of the Faculty of Pharmaceutical Medicine who are registered in the Faculty's CPD scheme can count participation in Experimental Therapeutics modules towards their CPD record. Non-members may wish to obtain further advice about CPD credit from their Royal College or Faculty.
To complete the MSc, students need to:
Attend the six modules and complete an assessed written assignment for each module.
Complete a dissertation on a topic chosen in consultation with a supervisor and the Course Director.
The dissertation is founded on a research project that builds on material studied in the taught modules. The dissertation should normally not exceed 15,000 words.
The project will normally be supervised by an academic supervisor from the University of Oxford, and an employer-based mentor.
The following are topics of dissertations completed by previous students on the course:
- The outcomes of non-surgical management of tubal pregnancy; a 6 month study of the South East London population
- Analysis of the predictive and prognostic factors of outcome in a cohort of patients prospectively treated with perioperative chemotherapy for adenocarcinoma of the stomach or of the gastroesophageal junction
- Evolution of mineral and bone disorder in early Chronic Kidney Disease (CKD): the role of FGF23 and vitamin D
- Survey of patients' knowledge and perception of the adverse drug reporting scheme (yellow cards) in primary care
- The predictive role of ERCC1 status in oxaliplatin based Neoadjuvant for metastatic colorectal cancer (CRC) to the liver
- Endothelial Pathophysiology in Dengue - Dextran studies during acute infection
- Literature review of the use of thalidomide in cancer
- An investigation into the phenotypical and functional characteristics of mesenchymal stem cells for clinical application
- Identification of genetic variants that cause capecitabine and bevacizumab toxicity
- Bridging the evidence gap in geriatric medicines via modelling and simulations
The class-based modules will include a period of preparatory study, a week of intensive face-to-face lectures and tutorials, followed by a period for assignment work. Attendance at modules will be a requirement for study. Some non-classroom activities will be provided at laboratory facilities elsewhere in the University. The course will include taught material on research skills. A virtual learning environment (VLE) will provide between-module support.
The taught modules will include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers. Practical work aims to develop the students' knowledge and understanding of the subject.
Find out how to apply here - http://www.ox.ac.uk/admissions/graduate/applying-to-oxford
In the Bio-Pharmaceutical Sciences master’s programme you are trained at the leading edge of drug-design and fundamental research of new drugs, optimization of existing drugs, and personalised medicine.
Despite major advances in drug-research, many common diseases such as cancers, neurological diseases, cardiovascular disease and other auto-immune diseases, lack effective treatment, or are found incurable. You are trained for a scientific career in drug research and development. Depending on your interest, you can choose from seven specialisations to further extend your scientific training and theoretical background.
Read more about our Bio-Pharmaceutical Sciences programme.
Find more reasons to study Bio-Pharmaceutical Sciences at Leiden University.
The master’s programme of Bio-Pharmaceutical Sciences (BPS) aims to train you in the research area of bio-pharmaceutical sciences and drug research in such a way that you have extensive knowledge and hands-on experience to be able to work independently as a scientific researcher. Moreover, you have a wide range of other career opportunities bio-pharmaceutical industry, science communication, and education.
This Clinical Pharmacology degree programme offers focused training which integrates basic and clinical sciences, and equips students with the essential skills required to function effectively as a clinical pharmacologist in the 21st century. As a student on the MSc Clinical Pharmacology programme, you will acquire core skills, enabling an appreciation of how to apply clinical pharmacological, regulatory and ethical principles to the optimisation of therapeutic practice and clinical research. Crucially, in addition to a firm grasp of the principles of molecular pharmacology, you will also gain foundational knowledge in the emerging science of pharmacogenomics and personalised medicine.
You will attend lectures, seminars and tutorials and take part in lab, project and team work.
In addition you will undertake a dissertation/project.
Career opportunities include positions in academia, health care and the pharmaceutical industry; returning to more advanced positions within a previous clinical environment (eg pharmacicts, clinicians); and PhD study.
The UK is one of the largest innovators and producers within biotechnology and pharmaceutical products with known multinationals providing treatments for large scale disease issues, newer companies providing batch customer medication and newer companies working with data and biotechnology researchers to provide customised medicines down to the individual level. The data and information now available with the advent of the Internet of Things and smart technologies has radically changed the way in which medicine and pharmacy can potentially be delivered in the future, opening up not just the possibility of customised medicines but also customised and specialist entrepreneurs within the field of biotech, pharmacy, and similar disciplines to provide high growth start up companies which address a real need for innovation within pharmacological areas and offer therapeutic treatments whilst we go about our every day lives.
Developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC) one of five innovation centres in Scotland some of which cross over in terms of innovation and technologies.Stratified Medicine holds huge potential to enhance timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new medicines.
If you are a person with ideas and a constant stream of research backing up your ideas and you have potential to be a company start up in this area the programme is directly aimed at getting your ideas off the ground and towards becoming a fully functioning enterprise in your own right in Scotland. You learn all there is to know about process innovation in order to progress your idea and samples through to small scale production testing whilst learning anything you didn't know about genome enabled medicines, biologic drug discovery, Pharmacokinetics and more. You get the best researchers to teach you as this programme is delivered in conjunction with the Stratified Medicine Scotland Innovation Centre partners.
You may be interested in reading about the Scottish Innovation Centres- to find out more information.
Find out more detail by visiting the programme web page
*Please be advised that some programmes have different tuition fees from those listed above and that some programmes also have additional costs.
Find out more about:
Find out more about living in Aberdeen and living costs
Stratified Medicine holds huge potential in the timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments. This taught postgraduate Masters programme draws on the current and future needs of the Life Sciences sector, to create a highly skilled workforce. It harnesses Scotland’s strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics to provide focused training which integrates basic and clinical sciences, and equips students with grounding in the essential skills required to design, execute and evaluate modern clinical interventions.
Students will undertake core courses which will account for 90 credits and a further 30 credits from options, which will enable students to personalise their degree to better align it with their future career aspirations. Students will also be offered a choice of project.
Project and assessment
The project will account for the remaining 60 credits. The programme will include an opportunity for all students to present the outcomes of their projects to an audience of other students and academics. Assessment will consist of submission of a dissertation and a viva examination.
Graduates of this programme will be competitive applicants for the positions in the commercial life sciences sector, or for PhD study in an academic or combined commercial/academic environment.
The Clinical Pharmacology course will give you the advanced skills and knowledge to evaluate the safety of new medicinal products in preparation for medical approval. It is one of three modular programmes in Pharmaceutical Medicine designed for working physicians, clinical scientists and allied health professionals interested in the clinical development process.
Clinical Pharmacology is the study of how drugs influence human physiology and the way the body responds. This study forms a vital part of the clinical development of new medicines and requires an advanced understanding of pre-clinical science, as well as the ethical and legal requirements for specialist research programmes. A well-designed clinical pharmacology programme informs the final regulatory of a new medicine. Therefore, generating skilled clinical pharmacologists is critical for the efficiency of future drug development.
This course will provide you with a broad knowledge and understanding of the drug development process and the medical aspects of the marketing of pharmaceutical products. You will also have opportunities to undertake advanced research projects and the possibility of one or more thesis publications.
The study programme is made up of optional and required modules. The MSc pathway requires modules totalling 180 credits to complete the programme, including 60 credits from a dissertation of around 15,000 - 18,000 words. The Postgraduate Diploma pathway will require modules totalling 120 credits, while the Postgraduate Certificate will require you to study modules totalling of 60 credits to complete the course.
If you are studying full-time, you will complete the course in one year, from September to September. If you are studying for the MSc qualification part-time, your programme will take up to four years to complete. The Postgraduate Diploma and Certificate pathways are both part-time courses. The Postgraduate Diploma will take two to three years to complete and the Postgraduate Certificate up to two years.
This course is for those working in or seeking to work in the field of clinical drug development. It covers all aspects of the clinical development process through from the earliest studies to post marketing activities. It will enhance knowledge and skills in all aspects of clinical research, drug regulation and drug safety.
The primary method of assessment for this course is a combination of coursework and written examinations. The MSc study programme also requires a research and dissertation on the subject of clinical pharmacology.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.
Developed in partnership with the pharmaceutical industry, the four pathways of our MSc in Pharmaceutical Industrial Advanced Training (PIAT) are postgraduate-level training programmes designed for scientists and managers working in the pharmaceutical industry and NHS in the fields of product development, manufacturing and quality assurance.
Many of our units have been developed to support those seeking to build their QP portfolio and our team includes QPs who are willing to support your development through this pathway.
You can also take individual units as standalone CPD courses. Please contact us for further details of the units that can be taken.
We offer a three-day summer school each year to allow you to meet fellow students and your tutors while attending workshops to support your learning and development in the units.
For our Business Development and Licensing pathway, we offer a two-day winter school held in London that covers the units within this key course for business development executives.
Below are some links that may be useful if you're thinking about studying PIAT.
Example dissertation titles
Below are examples of previous dissertations undertaken on the PIAT course.
All units commence in April and October. You can see a list of units in the table below, or view units specific to each of the four pathways:
Our alumni have used the learning and opportunities gained from this course to advance their careers in a range of roles and areas.
Some have moved to management positions, while others have taken on roles with more responsibility, becoming team leaders, heads of projects or responsible for new and larger areas, regions or territories.
As part of the course, our students build networks of contacts and join a growing community of leaders within the industry.
This programme is unique as it combines the study of pharmaceutical technology, including pharmaceutical sciences, and medicines control.
It has been designed to provide you with an advanced theoretical knowledge of sciences that are related to disciplines in pharmaceutical sciences, and give you the skills you need for laboratory work in this area.
These disciplines include the development of pharmaceutical formulation, with particular emphasis on the technology used in the pharmaceutical process and the development and production of medicines. This focus leads to an emphasis on the processes and procedures for clinical trials that are needed for licensing and regulation.
Medicines control is an important element of this programme. It encompasses drug regulations, drug licensing, drug testing, and safety. You will learn about the key processes involved in structured enforcement and inspection standards through the application of quality assurance. You will also gain knowledge and develop skills related to pharmaceutical supply chains and pharmacovigilance, including the safe and proper use of medicines.
You'll also have opportunities for hands-on experience in applying analytical and characterisation techniques such as liquid chromatography (LC) and gas chromatography (GC) combined with tandem mass spectrometric (MS/MS) detection, X-ray diffraction, scanning electron microscopy and near-infrared (NIR), nuclear magnetic resonance (NMR) and Raman spectroscopy.
The programme structure is modular and the taught components run over two semesters (September to January then late-January to May), with the research project taking place between May and August.
In the first semester you will take three core modules worth 60 credits. In the second semester you will take two core modules (which constitute 40 credits) and you will have the choice of two option modules (worth a further 20 credits). The research project is worth 60 credits.
A wide variety of teaching and learning methods are employed to engage you in developing your subject knowledge and understanding including:
The programme will progress from structured learning led by lectures and practicals, through to more seminar-based learning and to the individual research-based dissertation and project.
Different methods of assessment will be used as appropriate to the learning outcomes, including written examinations, oral presentations, experimental coursework reports, and, most importantly, an MSc dissertation.
You will have access to sophisticated state-of-the-art laboratories and equipment for practical classes and MSc projects. These include:
Graduates from our MSc Pharmaceutical Technology and Medicines Control programme progress into PhD research and employment in the pharmaceutical industry in various areas such as formulation and drug development, manufacture and production, pharmaceutical analysis, quality assurance and quality control.
The programme enhances graduate employment prospects, and opens up opportunities in government regulatory agencies, drug procurement and distribution centres.
Recent graduates have secured positions such as:
Awarded studentships from universities in the UK to undertake PhD studies:
The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.
Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.
Our comprehensive support services will help you to achieve your full potential – both academically and personally.
We provide all you need to make the very best of your time with us, and successfully progress through your studies and on into the world of graduate employment.
Our support services include:
We have well-stocked libraries and excellent IT facilities across campus. These facilities are open 24 hours a day during term time, meaning you’ll always find a place to get things done on campus.
Our Academic Skills Advice Service will work with you to develop your academic, interpersonal and transferable skills.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
The pharmaceutical industry and pharmacies are developed in a complex and highly regulated environment. Research of new drugs is quite expensive and you need enough time for it.
For that reason, pharmaceutical marketing professionals must be prepared to meet the challenges they encounter on the way to the success of the brands they manage.
This Master MBA with specialization in Pharmaceutical Marketing offers the opportunity to train and develop the skills in the field of business management, marketing, branding and digital communication in order to implement strategic plans to products, services or companies with the best strategy adapted to all current regulations.
This master aimed at the pharmaceutical industry claims that the student is able to implement a strategy to address successfully as well as enable you so you can evaluate the suitability of a business strategy, analyzing the marketing plan in which it is based, thus ensuring the desired results for your company.
MFI offers a flexible methodology adapted to your needs, whatever your geographical location or time availability. This master can be studied under:
All contents are fully updated and have great technical, easily understandable and with a clear practical vocation rigor. IMF offers you:
Continuous assessment as advances in the study of the Master. Each module will be assessed by combining online and development of case examination; overcoming will free each subject.
Likewise, obtaining master's degrees and Master MFI University Camilo José Cela, subject to overcoming each module testing and the development of a master work order.
Students who pass this master can work in:
Our Master of Research (MRes) in Translational Medicine will give you the research skills you need to use state-of-the-art biotechnologies to rapidly translate disease research into improved clinical healthcare.
Our understanding of the molecular basis of disease and drug mechanisms has improved dramatically in recent years, yet there is a distinct shortage of individuals able to apply this knowledge into effective clinical benefit. The core aim is to train the next generation of scientists able to 'fast-track' biological and scientific data into advanced therapies and diagnostics tools.
With advances in technology, graduates are faced with heightened expectations to conduct effective bioscience research. Employers demand skillsets with biological, medical, physical and computational characteristics, and our course is designed to provide this breadth of training.
You will learn omics skills and techniques such as genetics, genomics, transcriptomics, proteomics and metabolomics. Our training in metabolomic techniques is novel for a UK course, while our teaching on the integration of different omic platforms and data in a systems medicine strategy is also unique.
The MRes course consists of four taught units - which together make up the PGCert - plus an extended 35-week project that can be undertaken at the University, the Manchester Cancer Research Centre or a teaching hospital in Greater Manchester.
You can choose from a range of projects covering areas such as the use of gene expression profiling, proteomics, metabolomics, stem cell research, tissue culture or pharmacogenetics in the biology of cancer, cardiovascular disease, infectious diseases, stroke or diabetes.
Completing our course will open up a route into PhD research. You may also pursue a career in academia or the pharmaceutical or biotechnology industries, or as a clinical academic.
Extensive research experience
The 35-week research project for the MRes award offers the chance to conduct ambitious projects in areas such as cancer, cardiovascular disease, inflammation, mental health, infectious diseases, stroke or diabetes, using methods such as stem cell research, proteomics, metabolomics, tissue culture or pharmacogenetics.
Integrated focus on key topics
Our course has a strong and integrated focus on genetics, genomics, proteomics and metabolomics biotechnology and data interpretation, which are strengths within Manchester and are identified as core areas of bioscience growth.
Teaching comprises four taught units delivered using a variety of face-to-face, workshop and e-learning approaches and an extended 35-week research project for the MRes award.
Examples of research projects include the following.
Find out more by visiting the postgraduate teaching and learning page.
More than 50% of our graduates progress into PhD research at Manchester or other universities such as Cambridge, Imperial College London, Newcastle, Glasgow, Liverpool and Bristol.
Around 15% pursue a career in the pharmaceutical or biotechnology industry in the UK or abroad.
Approximately 25% are intercalating medics who complete their medical education. An estimated 10% pursue an undergraduate medical degree.